Amitriptyline for bedwetting is not the first treatment most families encounter, nor is it the most commonly prescribed. However, for some children, particularly those who have not responded to alarms or desmopressin, it remains a legitimate clinical option. If a specialist has mentioned it or you have read about it and want to understand what it involves, this article provides clear facts.
## What Is Amitriptyline and Why Is It Used for Bedwetting?
Amitriptyline is a tricyclic antidepressant. While this may sound alarming in the context of bedwetting, it is prescribed at much lower doses than those used for depression—typically 10–25mg in children, compared with 75–150mg or more for mood disorders. The exact mechanism by which it reduces bedwetting is not fully understood, but it is thought to act on bladder contractions, reduce sleep depth (making arousal easier), and possibly influence ADH-related signalling. It has been used off-label for nocturnal enuresis for decades.
In the UK, amitriptyline is not a first-line treatment for bedwetting. NICE guidance (CG111) recommends the bedwetting alarm as the preferred initial intervention for children aged 5 and over, with desmopressin as the recommended medication. Amitriptyline is considered further down the treatment pathway—typically only when other options have failed, are contraindicated, or when a specialist judges it appropriate. If you are at this stage, there is more context in this article on what comes next when standard treatments have not worked.
## What Does the Evidence Say?
The evidence for amitriptyline in bedwetting is modest but real. Studies show a reduction in wet nights compared with placebo. A Cochrane review found tricyclic antidepressants more effective than placebo during treatment; however, relapse rates after stopping are high—comparable to, or higher than, those seen with desmopressin. The medication suppresses symptoms while being taken but does not typically cure the underlying issue.
There is no strong evidence that amitriptyline outperforms desmopressin or alarms in head-to-head comparisons. Due to its side effect profile, it is used cautiously. It is not recommended in children under 6, and some clinicians set a higher age threshold.
## Who Might Be Offered Amitriptyline?
In practice, amitriptyline is considered in specific situations:
– Desmopressin has not worked or has stopped working
– Alarm therapy has been unsuccessful after an adequate trial
– The child has comorbidities such as anxiety, ADHD, or chronic pain, where amitriptyline might address multiple issues at low doses
– The child has not responded to combination therapy (alarm plus desmopressin)
– Short-term targeted use, such as during a school trip or holiday when other options are insufficient
The decision should always come from a paediatrician or specialist. GPs may prescribe it occasionally, but it is more appropriate within secondary care or a specialist clinic. If your GP has declined a referral and you believe one is needed, this guide on requesting a referral may help.
## Side Effects and Safety
This is the section most parents want to read carefully. Amitriptyline has a broader side effect profile than desmopressin. Common effects at low doses include:
– Drowsiness or sedation (especially in the first weeks)
– Dry mouth
– Constipation—already a concern in children with bedwetting, as constipation can worsen enuresis independently
– Blurred vision
– Mood changes or increased irritability in some children
Serious concerns relate to cardiac effects. Tricyclics can affect the electrical conduction of the heart, with reports of arrhythmias and overdose fatalities. Prescribing guidelines typically require an ECG before starting treatment, and the medication must be kept securely out of reach due to the risk of accidental ingestion and the narrower margin between therapeutic and toxic doses.
This is not a reason to avoid consideration but underscores the importance of management by a clinician with appropriate oversight.
## How It Is Prescribed and Monitored
A typical protocol involves:
1. Baseline ECG
2. Starting at the lowest appropriate dose (often 10mg for younger or smaller children)
3. Review after 4–6 weeks to assess response and side effects
4. Dose adjustment if needed, within safe limits
5. A plan for stopping—generally tapering rather than abrupt cessation
It is not intended for indefinite use without reassessment. If there is no meaningful response after an adequate trial, the clinician will usually recommend stopping.
## What Happens When You Stop?
Most children experience a return of bedwetting after stopping amitriptyline. This aligns with evidence that medications for enuresis tend to suppress symptoms rather than resolve the underlying issue. Some children may remain dry after stopping, especially if natural maturation coincides with treatment, but this cannot be predicted.
Discussing this with your child’s clinician beforehand helps set realistic expectations. Medication alone is rarely a complete solution for long-term dryness.
## Combining Amitriptyline With Other Management
Amitriptyline does not need to be the sole strategy. Most families continue overnight protection—such as pull-ups, taped briefs, or bed pads—to manage wet nights. Both medication and practical protection aim to reduce the impact on the child and family.
If wet nights persist despite medication, the product choice may not match the volume or sleep position. Understanding why pull-ups leak can help you make more effective choices during treatment.
## Talking to Your Child About It
Children old enough for amitriptyline should receive honest, age-appropriate explanations. You do not need to mention it as an antidepressant—instead, explain that it helps the bladder send the right signals at night. Emphasise that they are taking a tablet each evening, why it needs to be taken consistently, and that it should be kept safe. Involving them in the process, without overloading with clinical details, supports compliance and reduces anxiety. More guidance on honest conversations is available in this article.
## Summary: What Parents Should Weigh Up
Amitriptyline is a third-line treatment—used when standard options have been exhausted—due to its safety profile requiring careful oversight. Evidence supports its effectiveness during treatment, but relapse is common after stopping. Cardiac precautions are essential and should not be bypassed.
For families offered amitriptyline by a specialist, it is a legitimate next step—not a last resort. Like all enuresis treatments, it works for some children and not others, and the decision should involve your clinical team and you.
If you are unsure whether all other options have been explored, review your child’s treatment pathway before accepting or declining this option.